Akiyoshi Ohtake
Applied Pharmacology Research Laboratories
Drug Discovery Research
Astellas Pharma Inc.
Tsukuba-shi
Japan
Name/email consistency: high
- The forefront for novel therapeutic agents based on the pathophysiology of lower urinary tract dysfunction: ameliorative effect of solifenacin succinate (Vesicare), a bladder-selective antimuscarinic agent, on overactive bladder symptoms, especially urgency episodes. Ohtake, A., Sato, S., Sasamata, M., Miyata, K. J. Pharmacol. Sci. (2010)
- Pharmacological characterization of a new antimuscarinic agent, solifenacin succinate, in comparison with other antimuscarinic agents. Ohtake, A., Saitoh, C., Yuyama, H., Ukai, M., Okutsu, H., Noguchi, Y., Hatanaka, T., Suzuki, M., Sato, S., Sasamata, M., Miyata, K. Biol. Pharm. Bull. (2007)
- Effects of tamsulosin on resting urethral pressure and arterial blood pressure in anaesthetized female dogs. Ohtake, A., Sato, S., Sasamata, M., Miyata, K. J. Pharm. Pharmacol. (2006)
- Effect of tamsulosin on spontaneous bladder contraction in conscious rats with bladder outlet obstruction: comparison with effect on intraurethral pressure. Ohtake, A., Ukai, M., Saitoh, C., Sonoda, R., Noguchi, Y., Okutsu, H., Yuyama, H., Sato, S., Sasamata, M., Miyata, K. Eur. J. Pharmacol. (2006)